Table 5.
Spearman’s Rho for the correlation between the impact of treatment (M1-D0) on variables and on quality of life.
| M1-D0 | QoL-AD |
|---|---|
| MMSE | 0.413 |
| MDRS | 0.706 |
| MDRS Attention | 0.633 |
| MDRS I/P | 0.545 |
| MDRS Memory | 0.695 |
| MDRS Conceptualization | −0.222 |
| COT | −0.691 |
| TMT-A | −0.109 |
| TMT B-A | 0.200 |
| IST | 0.701 |
| DMS-48 | 0.390 |
| DO-30 | 0.241 |
| BDI | −0.768 * |
| HDRS-21 | −0.412 |
| STAI-YA | −0.337 |
| STAI-YB | −0.736 * |
BDI Beck Depression Inventory, COT Crossing Off Test, DMS-48 Delayed Matching-to-Sample task, DO-30 Oral picture naming test, HDRS-21 21-items Hamilton Depression Rating Scale, IST Isaac’s Set Test, MDRS Mattis Dementia Rating Scale, MDRS I/P initiation/perseveration subscale, MMSE MiniMental State Examination, QoL-AD Quality of Life in Alzheimer’s Disease scale, STAI-YA and YB State-Trait Anxiety Inventory forms YA and YB, TMT-A Trail Making Test-Part A, TMT B-A Trail Making Test Part B-Part A. * p < 0.05.